1. Home
  2. BREA vs EVOK Comparison

BREA vs EVOK Comparison

Compare BREA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • EVOK
  • Stock Information
  • Founded
  • BREA 2022
  • EVOK 2007
  • Country
  • BREA Ireland
  • EVOK United States
  • Employees
  • BREA N/A
  • EVOK N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BREA Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • BREA Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • BREA 8.7M
  • EVOK 7.4M
  • IPO Year
  • BREA 2023
  • EVOK 2013
  • Fundamental
  • Price
  • BREA $0.63
  • EVOK $4.95
  • Analyst Decision
  • BREA
  • EVOK
  • Analyst Count
  • BREA 0
  • EVOK 0
  • Target Price
  • BREA N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • BREA 104.1K
  • EVOK 10.1K
  • Earning Date
  • BREA 01-03-2025
  • EVOK 03-13-2025
  • Dividend Yield
  • BREA N/A
  • EVOK N/A
  • EPS Growth
  • BREA N/A
  • EVOK N/A
  • EPS
  • BREA N/A
  • EVOK N/A
  • Revenue
  • BREA $2,872,101.00
  • EVOK $8,617,036.00
  • Revenue This Year
  • BREA N/A
  • EVOK $97.35
  • Revenue Next Year
  • BREA N/A
  • EVOK $99.52
  • P/E Ratio
  • BREA N/A
  • EVOK N/A
  • Revenue Growth
  • BREA 2338.69
  • EVOK 100.35
  • 52 Week Low
  • BREA $0.50
  • EVOK $3.54
  • 52 Week High
  • BREA $3.00
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • BREA 40.04
  • EVOK 59.77
  • Support Level
  • BREA $0.62
  • EVOK $4.68
  • Resistance Level
  • BREA $0.69
  • EVOK $4.94
  • Average True Range (ATR)
  • BREA 0.05
  • EVOK 0.28
  • MACD
  • BREA -0.01
  • EVOK 0.06
  • Stochastic Oscillator
  • BREA 15.31
  • EVOK 73.58

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: